Steripath Initial Specimen Diversion Device (ISDD) from Magnolia Medical Technologies is a mechanical blood culture collection device that has been clinically proven to help eliminate blood culture contamination, which can lead to the misdiagnosis of bloodstream infections including sepsis. A closed-system device, the Steripath ISDD mechanically diverts, sequesters, and isolates the initial 1.5-2.0 mL of blood, the portion known to contain contaminants. The device then opens an independent, second sterile blood flow path to the culture bottles. The US Department of Veterans Affairs has awarded Magnolia a five-year Federal Supply Schedule contract to provide the Steripath ISDD for use in the system’s hospitals and treatment facilities, including hospitals and medical centers of the Department of Veterans Affairs (VA) and Department of Defense (DoD).